Crenolanib

An orally bioavailable benzimidazole targeting the platelet-derived growth factor receptor (PDGFR) subtypes alpha and beta and FMS-related tyrosine kinase 3 (Flt3), with potential antineoplastic activity. Upon oral administration, crenolanib binds to and inhibits both wild-type and mutated forms of PDGFR and Flt3, which may result in the inhibition of PDGFR- and Flt3-related signal transduction pathways. This results in inhibition of tumor angiogenesis and tumor cell proliferation in PDGFR and/or Flt3 overexpressing tumor cells. PDGFR and Flt3, class III receptor tyrosine kinases, are upregulated or mutated in many tumor cell types. (NCI Thesaurus)

YOU MAY ALSO LIKE

Crenated Cell Measurement

The determination of the number of crenated red blood cells present in a sample.

Creme de Menthe Flavor

A characteristic of a medicinal product, specifying that its most predominant agreeable savor detected by the unified sensation of taste and olfactory…

Credential

A document that qualifies somebody to do something, provides authentication for a claim, or confirms position or status.

CREBL2 wt Allele

Human CREBL2 wild-type allele is located in the vicinity of 12p13 and is approximately 33 kb in length. This allele, which encodes…

CREBL2 Gene

This gene plays a role in transcriptional regulation and mediates DNA-binding interactions.

CREBBP wt Allele

Human CREBBP wild-type allele is located in the vicinity of 16p13.3 and is approximately 154 kb in length. This allele, which encodes…